Global Brucellosis Vaccines Competitive Landscape Professional Research Report 2024

Report Format: PDF   |   Report ID: 5685899   |   Published Date: August 2024   |   Pages:  170+  

Research Summary
Brucellosis vaccines are immunizations designed to protect against brucellosis, a bacterial infection caused by species of the Brucella genus. Brucellosis affects various animals, including livestock such as cattle, goats, and pigs, as well as humans. The vaccines developed for brucellosis primarily target livestock populations, as they play a significant role in transmission to humans through consumption of contaminated animal products. Brucellosis vaccines are typically composed of live attenuated or inactivated Brucella strains, which stimulate the immune system to produce protective antibodies against the bacteria. These vaccines are administered to animals, either as a single-dose or multiple-dose regimen, to prevent or reduce the incidence of brucellosis in livestock populations. Vaccination programs are crucial in controlling and eradicating brucellosis, as they help reduce the spread of the disease, minimize economic losses in livestock production, and prevent zoonotic infections in humans. Effective brucellosis vaccines are an essential tool in managing this globally significant bacterial infection.
According to DIResearch's in-depth investigation and research, the global Brucellosis Vaccines market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of Brucellosis Vaccines include Jinyu, Colorado Serum, Boehringer Ingelheim, Biogenesis-Bago, Vetal Company, CZ Veterinaria, SYVA Laboratorios, Indian Immunologicals, Qilu, Tecnovax, Zoetis, Hester Biosciences, Onderstepoort Biological, Instituto Rosenbusch, Ceva Sante Animale, Calier & Biologicos Laverlam, Biovet etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Brucellosis Vaccines. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Brucellosis Vaccines market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Brucellosis Vaccines market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Brucellosis Vaccines industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Brucellosis Vaccines Include:
Jinyu
Colorado Serum
Boehringer Ingelheim
Biogenesis-Bago
Vetal Company
CZ Veterinaria
SYVA Laboratorios
Indian Immunologicals
Qilu
Tecnovax
Zoetis
Hester Biosciences
Onderstepoort Biological
Instituto Rosenbusch
Ceva Sante Animale
Calier & Biologicos Laverlam
Biovet
Brucellosis Vaccines Product Segment Include:
S19 Vaccine
RB51 Vaccine Strain
Brucellosis Vaccines Product Application Include:
Cattle
Sheep
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Brucellosis Vaccines Industry PESTEL Analysis
Chapter 3: Global Brucellosis Vaccines Industry Porter's Five Forces Analysis
Chapter 4: Global Brucellosis Vaccines Major Regional Market Size and Forecast Analysis
Chapter 5: Global Brucellosis Vaccines Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Brucellosis Vaccines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Brucellosis Vaccines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Brucellosis Vaccines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Brucellosis Vaccines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Brucellosis Vaccines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Brucellosis Vaccines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Brucellosis Vaccines Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents

1 Brucellosis Vaccines Market Overview

1.1 Product Definition and Statistical Scope

1.2 Brucellosis Vaccines Product by Type

1.2.1 Global Brucellosis Vaccines Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 S19 Vaccine

1.2.3 RB51 Vaccine Strain

1.3 Brucellosis Vaccines Product by Application

1.3.1 Global Brucellosis Vaccines Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Cattle

1.3.3 Sheep

1.3.4 Others

1.4 Global Brucellosis Vaccines Market Revenue Analysis (2019-2030)

1.5 Brucellosis Vaccines Market Development Status and Trends

1.5.1 Brucellosis Vaccines Industry Development Status Analysis

1.5.2 Brucellosis Vaccines Industry Development Trends Analysis

2 Brucellosis Vaccines Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 Brucellosis Vaccines Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global Brucellosis Vaccines Market Analysis by Regions

4.1 Brucellosis Vaccines Overall Market: 2023 VS 2024 VS 2030

4.2 Global Brucellosis Vaccines Revenue and Forecast Analysis (2019-2030)

4.2.1 Global Brucellosis Vaccines Revenue and Market Share by Region (2019-2024)

4.2.2 Global Brucellosis Vaccines Revenue Forecast by Region (2025-2030)

5 Global Brucellosis Vaccines Market Size by Type and Application

5.1 Global Brucellosis Vaccines Market Size by Type

5.2 Global Brucellosis Vaccines Market Size by Application

6 North America

6.1 North America Brucellosis Vaccines Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America Brucellosis Vaccines Market Size by Type

6.4 North America Brucellosis Vaccines Market Size by Application

6.5 North America Brucellosis Vaccines Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe Brucellosis Vaccines Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe Brucellosis Vaccines Market Size by Type

7.4 Europe Brucellosis Vaccines Market Size by Application

7.5 Europe Brucellosis Vaccines Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China Brucellosis Vaccines Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China Brucellosis Vaccines Market Size by Type

8.4 China Brucellosis Vaccines Market Size by Application

9 APAC (excl. China)

9.1 APAC (excl. China) Brucellosis Vaccines Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) Brucellosis Vaccines Market Size by Type

9.4 APAC (excl. China) Brucellosis Vaccines Market Size by Application

9.5 APAC (excl. China) Brucellosis Vaccines Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America Brucellosis Vaccines Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America Brucellosis Vaccines Market Size by Type

10.4 Latin America Brucellosis Vaccines Market Size by Application

10.5 Latin America Brucellosis Vaccines Market Size by Country

10.5.1 Mecixo

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa Brucellosis Vaccines Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa Brucellosis Vaccines Market Size by Type

11.4 Middle East & Africa Brucellosis Vaccines Market Size by Application

11.5 Middle East & Africa Brucellosis Vaccines Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Market Competition by Manufacturers

12.1 Global Brucellosis Vaccines Market Revenue by Key Manufacturers (2020-2024)

12.2 Brucellosis Vaccines Competitive Landscape Analysis and Market Dynamic

12.2.1 Brucellosis Vaccines Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 Jinyu

13.1.1 Jinyu Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 Jinyu Brucellosis Vaccines Product Portfolio

13.1.3 Jinyu Brucellosis Vaccines Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.2 Colorado Serum

13.2.1 Colorado Serum Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 Colorado Serum Brucellosis Vaccines Product Portfolio

13.2.3 Colorado Serum Brucellosis Vaccines Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.3 Boehringer Ingelheim

13.3.1 Boehringer Ingelheim Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 Boehringer Ingelheim Brucellosis Vaccines Product Portfolio

13.3.3 Boehringer Ingelheim Brucellosis Vaccines Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.4 Biogenesis-Bago

13.4.1 Biogenesis-Bago Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 Biogenesis-Bago Brucellosis Vaccines Product Portfolio

13.4.3 Biogenesis-Bago Brucellosis Vaccines Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.5 Vetal Company

13.5.1 Vetal Company Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 Vetal Company Brucellosis Vaccines Product Portfolio

13.5.3 Vetal Company Brucellosis Vaccines Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.6 CZ Veterinaria

13.6.1 CZ Veterinaria Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 CZ Veterinaria Brucellosis Vaccines Product Portfolio

13.6.3 CZ Veterinaria Brucellosis Vaccines Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.7 SYVA Laboratorios

13.7.1 SYVA Laboratorios Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 SYVA Laboratorios Brucellosis Vaccines Product Portfolio

13.7.3 SYVA Laboratorios Brucellosis Vaccines Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.8 Indian Immunologicals

13.8.1 Indian Immunologicals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 Indian Immunologicals Brucellosis Vaccines Product Portfolio

13.8.3 Indian Immunologicals Brucellosis Vaccines Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.9 Qilu

13.9.1 Qilu Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.9.2 Qilu Brucellosis Vaccines Product Portfolio

13.9.3 Qilu Brucellosis Vaccines Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.10 Tecnovax

13.10.1 Tecnovax Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.10.2 Tecnovax Brucellosis Vaccines Product Portfolio

13.10.3 Tecnovax Brucellosis Vaccines Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.11 Zoetis

13.11.1 Zoetis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.11.2 Zoetis Brucellosis Vaccines Product Portfolio

13.11.3 Zoetis Brucellosis Vaccines Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.12 Hester Biosciences

13.12.1 Hester Biosciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.12.2 Hester Biosciences Brucellosis Vaccines Product Portfolio

13.12.3 Hester Biosciences Brucellosis Vaccines Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.13 Onderstepoort Biological

13.13.1 Onderstepoort Biological Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.13.2 Onderstepoort Biological Brucellosis Vaccines Product Portfolio

13.13.3 Onderstepoort Biological Brucellosis Vaccines Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.14 Instituto Rosenbusch

13.14.1 Instituto Rosenbusch Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.14.2 Instituto Rosenbusch Brucellosis Vaccines Product Portfolio

13.14.3 Instituto Rosenbusch Brucellosis Vaccines Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.15 Ceva Sante Animale

13.15.1 Ceva Sante Animale Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.15.2 Ceva Sante Animale Brucellosis Vaccines Product Portfolio

13.15.3 Ceva Sante Animale Brucellosis Vaccines Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.16 Calier & Biologicos Laverlam

13.16.1 Calier & Biologicos Laverlam Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.16.2 Calier & Biologicos Laverlam Brucellosis Vaccines Product Portfolio

13.16.3 Calier & Biologicos Laverlam Brucellosis Vaccines Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.17 Biovet

13.17.1 Biovet Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.17.2 Biovet Brucellosis Vaccines Product Portfolio

13.17.3 Biovet Brucellosis Vaccines Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 Brucellosis Vaccines Industry Chain Analysis

14.2 Brucellosis Vaccines Industry Raw Material and Suppliers Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 Brucellosis Vaccines Typical Downstream Customers

14.4 Brucellosis Vaccines Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer


Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:

Publisher: DIResearch
Choose License
Related Reports

Why Market Study Report?


  • Best Price for Reports
  • Large Report Database
  • Easily Customize Reports
  • 24/7 Email & Phone Support